Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis-Reference-Cited by-同舟云学术

Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis

Published:2019-04 Issue: Volume:314 Page:82-90
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Pol Suyog,Schweser Ferdinand,Bertolino Nicola,Preda Marilena,Sveinsson Michele,Sudyn Michelle,Babek Natan,Zivadinov Robert^ORCID

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference44 articles.

1. Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair;Abiraman;J. Neurosci.,2015

2. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis;Absinta;Neurology,2015

3. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool;Ajami;Nat. Neurosci.,2011

4. Lymphoid neogenesis in chronic inflammatory diseases;Aloisi;Nat. Rev. Immunol.,2006

5. Preclinical detection of leptomeningeal inflammation using contrast-enhanced FLAIR at 9.4T in the EAE-MOG mouse model of Multiple Sclerosis;Bertolino,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance;PLOS ONE;2024-05-29

2. Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance;2024-03-07

3. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-01

4. Delimiting MOGAD as a disease entity using translational imaging;Frontiers in Neurology;2023-12-07

5. Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study;Multiple Sclerosis Journal;2023-09-23